These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 32483360)
1. Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. Zviran A; Schulman RC; Shah M; Hill STK; Deochand S; Khamnei CC; Maloney D; Patel K; Liao W; Widman AJ; Wong P; Callahan MK; Ha G; Reed S; Rotem D; Frederick D; Sharova T; Miao B; Kim T; Gydush G; Rhoades J; Huang KY; Omans ND; Bolan PO; Lipsky AH; Ang C; Malbari M; Spinelli CF; Kazancioglu S; Runnels AM; Fennessey S; Stolte C; Gaiti F; Inghirami GG; Adalsteinsson V; Houck-Loomis B; Ishii J; Wolchok JD; Boland G; Robine N; Altorki NK; Landau DA Nat Med; 2020 Jul; 26(7):1114-1124. PubMed ID: 32483360 [TBL] [Abstract][Full Text] [Related]
2. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients. Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953 [No Abstract] [Full Text] [Related]
3. Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing. Mansukhani S; Barber LJ; Kleftogiannis D; Moorcraft SY; Davidson M; Woolston A; Proszek PZ; Griffiths B; Fenwick K; Herman B; Matthews N; O'Leary B; Hulkki S; Gonzalez De Castro D; Patel A; Wotherspoon A; Okachi A; Rana I; Begum R; Davies MN; Powles T; von Loga K; Hubank M; Turner N; Watkins D; Chau I; Cunningham D; Lise S; Starling N; Gerlinger M Clin Chem; 2018 Nov; 64(11):1626-1635. PubMed ID: 30150316 [TBL] [Abstract][Full Text] [Related]
4. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants. Razavi P; Li BT; Brown DN; Jung B; Hubbell E; Shen R; Abida W; Juluru K; De Bruijn I; Hou C; Venn O; Lim R; Anand A; Maddala T; Gnerre S; Vijaya Satya R; Liu Q; Shen L; Eattock N; Yue J; Blocker AW; Lee M; Sehnert A; Xu H; Hall MP; Santiago-Zayas A; Novotny WF; Isbell JM; Rusch VW; Plitas G; Heerdt AS; Ladanyi M; Hyman DM; Jones DR; Morrow M; Riely GJ; Scher HI; Rudin CM; Robson ME; Diaz LA; Solit DB; Aravanis AM; Reis-Filho JS Nat Med; 2019 Dec; 25(12):1928-1937. PubMed ID: 31768066 [TBL] [Abstract][Full Text] [Related]
5. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment. Widman AJ; Shah M; Frydendahl A; Halmos D; Khamnei CC; Øgaard N; Rajagopalan S; Arora A; Deshpande A; Hooper WF; Quentin J; Bass J; Zhang M; Langanay T; Andersen L; Steinsnyder Z; Liao W; Rasmussen MH; Henriksen TV; Jensen SØ; Nors J; Therkildsen C; Sotelo J; Brand R; Schiffman JS; Shah RH; Cheng AP; Maher C; Spain L; Krause K; Frederick DT; den Brok W; Lohrisch C; Shenkier T; Simmons C; Villa D; Mungall AJ; Moore R; Zaikova E; Cerda V; Kong E; Lai D; Malbari MS; Marton M; Manaa D; Winterkorn L; Gelmon K; Callahan MK; Boland G; Potenski C; Wolchok JD; Saxena A; Turajlic S; Imielinski M; Berger MF; Aparicio S; Altorki NK; Postow MA; Robine N; Andersen CL; Landau DA Nat Med; 2024 Jun; 30(6):1655-1666. PubMed ID: 38877116 [TBL] [Abstract][Full Text] [Related]
6. Methods for Measuring ctDNA in Lymphomas. Rossi D; Condoluci A; Spina V; Gaidano G Methods Mol Biol; 2019; 1881():253-265. PubMed ID: 30350211 [TBL] [Abstract][Full Text] [Related]
7. Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content. Ganesamoorthy D; Robertson AJ; Chen W; Hall MB; Cao MD; Ferguson K; Lakhani SR; Nones K; Simpson PT; Coin LJM BMC Cancer; 2022 Jan; 22(1):85. PubMed ID: 35057759 [TBL] [Abstract][Full Text] [Related]
8. Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial. Jovelet C; Ileana E; Le Deley MC; Motté N; Rosellini S; Romero A; Lefebvre C; Pedrero M; Pata-Merci N; Droin N; Deloger M; Massard C; Hollebecque A; Ferté C; Boichard A; Postel-Vinay S; Ngo-Camus M; De Baere T; Vielh P; Scoazec JY; Vassal G; Eggermont A; André F; Soria JC; Lacroix L Clin Cancer Res; 2016 Jun; 22(12):2960-8. PubMed ID: 26758560 [TBL] [Abstract][Full Text] [Related]
9. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls. Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568 [TBL] [Abstract][Full Text] [Related]
10. Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients. Tsui DWY; Cheng ML; Shady M; Yang JL; Stephens D; Won H; Srinivasan P; Huberman K; Meng F; Jing X; Patel J; Hasan M; Johnson I; Gedvilaite E; Houck-Loomis B; Socci ND; Selcuklu SD; Seshan VE; Zhang H; Chakravarty D; Zehir A; Benayed R; Arcila M; Ladanyi M; Funt SA; Feldman DR; Li BT; Razavi P; Rosenberg J; Bajorin D; Iyer G; Abida W; Scher HI; Rathkopf D; Viale A; Berger MF; Solit DB Genome Med; 2021 May; 13(1):96. PubMed ID: 34059130 [TBL] [Abstract][Full Text] [Related]
11. Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort. Chen X; Chang CW; Spoerke JM; Yoh KE; Kapoor V; Baudo C; Aimi J; Yu M; Liang-Chu MMY; Suttmann R; Huw LY; Gendreau S; Cummings C; Lackner MR Clin Cancer Res; 2019 Apr; 25(7):2254-2263. PubMed ID: 30617129 [TBL] [Abstract][Full Text] [Related]
12. Using plasma cell-free DNA to monitor the chemoradiotherapy course of cervical cancer. Tian J; Geng Y; Lv D; Li P; Cordova M; Liao Y; Tian X; Zhang X; Zhang Q; Zou K; Zhang Y; Zhang X; Li Y; Zhang J; Ma Z; Shao Y; Song L; Owen GI; Li T; Liu R; Liu Q; Zou L; Zhang Z; Li Z Int J Cancer; 2019 Nov; 145(9):2547-2557. PubMed ID: 30919951 [TBL] [Abstract][Full Text] [Related]
13. Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNA. Frydendahl A; Rasmussen MH; Jensen SØ; Henriksen TV; Demuth C; Diekema M; Ditzel HJ; Wen SWC; Pedersen JS; Dyrskjøt L; Andersen CL Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673836 [TBL] [Abstract][Full Text] [Related]
14. Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients. Koeppel F; Blanchard S; Jovelet C; Genin B; Marcaillou C; Martin E; Rouleau E; Solary E; Soria JC; André F; Lacroix L PLoS One; 2017; 12(11):e0188174. PubMed ID: 29161279 [TBL] [Abstract][Full Text] [Related]
15. Genome-wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis. Wei T; Zhang J; Li J; Chen Q; Zhi X; Tao W; Ma J; Yang J; Lou Y; Ma T; Li X; Zhang Q; Chen W; Que R; Gao S; Bai X; Liang T Mol Oncol; 2020 Sep; 14(9):1966-1977. PubMed ID: 32593194 [TBL] [Abstract][Full Text] [Related]
16. Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer. Shen N; Zhang D; Yin L; Qiu Y; Liu J; Yu W; Fu X; Zhu B; Xu X; Duan A; Chen Z; Wang X; Cao X; Zhao T; Zhou Z; Yu L; Qin H; Fang Z; Li JY; Liu Y; Xiong L; Yuan B; Li F; Zhang Y Oncol Rep; 2019 Aug; 42(2):549-560. PubMed ID: 31173267 [TBL] [Abstract][Full Text] [Related]
17. Multiple-level copy number variations in cell-free DNA for prognostic prediction of HCC with radical treatments. Wang Y; Zhou K; Wang X; Liu Y; Guo D; Bian Z; Su L; Liu K; Gu X; Guo X; Wang L; Zhang H; Tao K; Xing J Cancer Sci; 2021 Nov; 112(11):4772-4784. PubMed ID: 34490703 [TBL] [Abstract][Full Text] [Related]
18. Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients. Palande V; Raviv Shay D; Frenkel-Morgenstern M J Vis Exp; 2020 Sep; (163):. PubMed ID: 32986022 [TBL] [Abstract][Full Text] [Related]
19. Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals. Xia L; Li Z; Zhou B; Tian G; Zeng L; Dai H; Li X; Liu C; Lu S; Xu F; Tu X; Deng F; Xie Y; Huang W; He J Sci Rep; 2017 Aug; 7(1):7526. PubMed ID: 28790338 [TBL] [Abstract][Full Text] [Related]
20. Unbiased Detection of Somatic Copy Number Aberrations in cfDNA of Lung Cancer Cases and High-Risk Controls with Low Coverage Whole Genome Sequencing. Taylor F; Bradford J; Woll PJ; Teare D; Cox A Adv Exp Med Biol; 2016; 924():29-32. PubMed ID: 27753014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]